₹16 crore drug is the hope for SMA patientsThe HinduFriday, February 12, 2021 03:39:15 AM UTCA gene therapy costing ₹16 crore is the only shot of life for nearly 200 children with Spinal Muscular Atrophy (SMA) Type 1, a rare genetic disease, in Karnataka.Read full story on The HinduShare this story on:-